Wall Street analysts expect Cencora (COR) to post quarterly earnings of $4.05 per share in its upcoming report, which indicates a year-over-year increase of 8.6%. Revenues are expected to be $85.97 billion, up 5.5% from the year-ago quarter.The current level reflects no revision in the consensus EPS estimate for the quarter over the past 30 days. This demonstrates how the analysts covering the stock have collectively reappraised their initial projections over this period.Ahead of a company's earnings disclo ...

Core Insights - Cencora reported revenue of $80.66 billion for the quarter ended June 2025, reflecting an 8.7% increase year-over-year and surpassing the Zacks Consensus Estimate of $80.33 billion by 0.41% [1] - The company's EPS for the quarter was $4.00, up from $3.34 in the same quarter last year, exceeding the consensus EPS estimate of $3.78 by 5.82% [1] Revenue Breakdown - Total U.S. Healthcare Solutions revenue was $72.88 billion, slightly above the average estimate of $72.81 billion, marking an 8.5% year-over-year increase [4] - Total International Healthcare Solutions revenue reached $7.79 billion, exceeding the average estimate of $7.3 billion, with a year-over-year growth of 10.5% [4] - Intersegment eliminations reported at $-3.47 million, better than the estimated $-3.89 million, showing a significant year-over-year change of 63.6% [4] Stock Performance - Cencora's shares have returned -1.9% over the past month, contrasting with the Zacks S&P 500 composite's increase of 0.5% [3] - The stock currently holds a Zacks Rank 2 (Buy), suggesting potential outperformance against the broader market in the near term [3]